Category survey

Function of Parkinson Disease Genes in Mitochondrial Quality Control Investments < €500k Canada 2016    

Role of HO-1 in Aging & Parkinsonian Neural Tissues III Investments < €500k Canada 2016    

Cortical connectivity in neurodevelopment and neurodegeneration Investments < €500k Canada 2016    

Reversal of neuronal and cerebrovascular pathology in Alzheimer’s disease Investments < €500k Canada 2016    

Involvement of AMPA receptor endocytosis in Alzheimers disease: Examining memory and structural plasticity deficits in mouse models Investments < €500k Canada 2016    

The impact of drug-induced dyskinesia and its management on the daily life activities of patients with Parkinson’s disease Investments < €500k Canada 2016    

Cellular responses to protein misfolding in aging cells Investments < €500k Canada 2016    

Generation of effective carbohydrate-based inhibitors of a glycosidase implicated in Alzheimer disease and their molecular mechanism of action. Investments < €500k Canada 2016    

Biology and pathobiology of alpha-synuclein Investments < €500k Canada 2016    

Neuroprotection and immunomodulation in the enteric nervous system for the treatment of Parkinson’s disease Investments < €500k Canada 2016    

A multi-hit model of Parkinson’s disease: LRRKing inflammatory mechanisms. Investments < €500k Canada 2016    

MicroRNA-15 dysregulation in sporadic Alzheimer’s disease: testing the “multiple hit” hypothesis in neurodegenerative disorders Investments < €500k Canada 2016    

Optimising fMRI Detection of Longitudinal Changes in Age-Related Brain Disorders Investments < €500k Canada 2016    

TRPML1 in intracellular Fe2+ and Ca2+ homeostasis/signaling Investments < €500k Canada 2016    

Post-Stroke Brain Deterioration: Role of Abeta and Neuroinflammation Investments < €500k Canada 2016    

Chemical-genetics approaches using in vivo models of age-dependent neurodegeneration Investments < €500k Canada 2016    

Structural and functional neuro-anatomical correlates of memory for context across the adult lifespan. Investments < €500k Canada 2016    

Effects of Oxidative / Nitrosative Stress and Aging on Cholinergic Neuron Function Investments < €500k Canada 2016    

Cerebrovascular pathophysiology in mouse models of Alzheimer’s disease Investments < €500k Canada 2016    

Dopaminergic Neuronal Survival During Aging and Neurodegenerative Stress Investments < €500k Canada 2016    

Computation and theory to predict structures and mechanisms for protein misfolding in amyotrophic lateral sclerosis Investments < €500k Canada 2016    

Neurofibrillary pathology and amyloidogenesis in Alzheimer’s disease: mechanistic insights Investments < €500k Canada 2016    

Structure-based design and discovery of improved anti-amyloidogenic compounds Investments < €500k Canada 2016    

PrP N-terminal sequences and biological endpoints in Prion and Alzheimer’s Disease Investments < €500k Canada 2016    

Establishment of a primate model that exhibits Alzheimer’s-like features to explore new preventative and therapeutic strategies. Investments < €500k Canada 2016    

The amyloid and beyond; A molecular answer to forget me not. Investments < €500k Canada 2016    

Dysfunction of cortical networks in Alzheimer’s disease Investments < €500k Canada 2016    

Functional ability assessment in early dementia and mild brain injury using cognitive-motor integration. Investments < €500k Canada 2016    

A Collaborative International Knowledge Synthesis to Update Guidelines for Determining Medical Fitness to Operate Motor Vehicles with Dementia Investments < €500k Canada 2016    

A Systematic Review and Meta-Analysis of the Accuracy of Depression Rating Scales to Diagnose Depression in Older Adults with Alzheimer’s Disease and Other Dementias Investments < €500k Canada 2016    

Maintaining independence in everyday life among seniors with subjective cognitive complaints. Investments < €500k Canada 2016    

Implementation and evaluation of a multi-component online resource for caregivers of persons with dementia Investments < €500k Canada 2016    

Integrated Software for the Assessment of Diffusion Tensor Imaging of Brain Wiring in Alzheimer’s Disease and Dementia Investments < €500k Canada 2016    

Role of the basal ganglia in inhibiting and promoting voluntary movements Investments < €500k Canada 2016    

The cognitive structure of decisions under risk and uncertainty in Parkinson’s disease Investments < €500k Canada 2016    

The impact of emotional mimicry and oxytocin on frontotemporal dementia Investments < €500k Canada 2016    

Development of an Automated System for Pain Detection and Monitoring in Older Adults with Dementia Investments < €500k Canada 2016    

A potential biomarker for vascular dementia Investments < €500k Canada 2016    

Lighting up the aging brain Investments < €500k Canada 2016    

Cognition and Obstructive Sleep Apnea in Parkinson’s Disease, Effect of Positive Airway Pressure Therapy (COPE-PAP Trial) Investments < €500k Canada 2016    

Troubles cognitifs légers et dépression gériatrique : comparaison de caractéristiques cliniques et analyse de l’évolution des patients vers la démence. Mild cognitive disorders and geriatric depression: comparison of clinical characteristics and analysis of the evolution of patients towards dementia Investments…

Delaying institutionalization, sustaining families: Comparative case studies of care at home for persons with dementia Investments < €500k Canada 2016    

Predementia neuroimaging TIA (PREVENT) study. Investments < €500k Canada 2016    

Microglial modulation, a potential therapeutic approach in neurodegenerative diseases Investments < €500k Canada 2016    

Basic and Patient-Oriented Dementia Research: Linking Novel Methods for Early Stage Detection with Understanding Pathological Mechanisms in Dementia Investments < €500k Canada 2016    

In vivo imaging of levodopa-induced angiogenesis and its relevance to tardive dyskinesia in a parkinsonian rat model Investments < €500k Canada 2016    

Mitochondrial imaging in live neurons from Parkinson’s disease patients Investments < €500k Belgium 2016    

Colllaborative project Munich-Sofia in the field of Dementia Investments < €500k Bulgaria 2016    

Danubian Network for Dementia education and care- Phase 2 Investments < €500k Bulgaria 2016    

Clinical, neuropsychological, neuroimaging, electrophysiological and biological makers for early diagnosis of neurodegenerative disorders with cognitive impairment Investments < €500k Bulgaria 2016